<![CDATA[The existence of Covid 19 pandemic that has spread throughout the world, including Indonesia, has resulted in the economic. Ever since the first positive cases of Covid-19 were announced in Indonesia, the market has reacted negatively. It can be seen from the performance of IHSG which was closed with a decline in value of 1.68% from the previous one.This study aims to analyze the reaction of the capital market in Indonesia to the presence of the Sinovac vaccine in Indonesia as a solution to suppress the spread of Covid-19. Market reaction is seen through averge abnormal return, cumulative averge abnormal return and trading volume activity before and after the arrival of the synovac vaccine. This study uses secondary data, obtained from the official website of the Indonesia Stock Exchange. The population of this study is the pharmaceutical sector companies listed on the IDX, with a total sample size of 9 companies in the observation period of November 30, 2020 to December 14, 2020. The results of this study indicate there is no differences in abnormal returns, cumulative abnormal returns and trading volume activity before and after the arrival of Vacsin Sinovac in Indonesia.]]>
Copyrights © 2021
